1
|
Alves YM, Berra TZ, de Jezus SV, Araújo VMS, Pinheiro JDS, de Assis LBDO, Canelonez M, Sacramento DS, Perez F, Maciel ELN, Arcêncio RA. Adherence to Short-Duration Treatment (3HP) for Latent Tuberculosis among International Migrants in Manaus, Amazonas: Evaluation of the Efficacy of Different Treatment Modalities. Microorganisms 2024; 12:1629. [PMID: 39203470 PMCID: PMC11356601 DOI: 10.3390/microorganisms12081629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2024] [Revised: 07/31/2024] [Accepted: 08/06/2024] [Indexed: 09/03/2024] Open
Abstract
Migration, a multifaceted phenomenon, has a significant impact on health. Migrants perform similar movement patterns within their country of origin, in transit, and in the country of destination, thus making it difficult to monitor TB treatment throughout the journey. The objective was to compare the effectiveness of different treatment modalities in adherence to the short-term regimen for LTBI (3HP) among international migrants and refugees. This is a quasi-experimental study conducted in Manaus-AM. The study population was made up of international migrants. The certification and monitoring of medication intake employed three strategies: self-administration (SA), directly observed conventional therapy (DOT), and Video Telemonitoring System for Tuberculosis Treatment (VDOT). The VDOT group and SA group exhibited the lowest rate of treatment dropout or interruption at 16.1%, followed by the DOT group at 23.1%. The results suggest that the most effective strategy for ensuring adherence among migrants and refugees was VDOT (OR_adj 0.26; CI 0.7-0.94), suggesting that migrants may be more likely to adhere to and complete their treatment. The results show that relying on different treatment strategies, adapted to the individuals' needs and risk factors, is a viable and effective way of providing person-centered TB care.
Collapse
Affiliation(s)
- Yan Mathias Alves
- Department of Maternal-Infant and Public Health Nursing, Ribeirão Preto College of Nursing, University of São Paulo, Ribeirão Preto 14040-902, Sao Paulo, Brazil; (Y.M.A.)
- Brazilian Tuberculosis Research Network (REDE-TB), Rio de Janeiro 21941-904, Rio de Janeiro, Brazil
| | - Thaís Zamboni Berra
- Department of Maternal-Infant and Public Health Nursing, Ribeirão Preto College of Nursing, University of São Paulo, Ribeirão Preto 14040-902, Sao Paulo, Brazil; (Y.M.A.)
- Brazilian Tuberculosis Research Network (REDE-TB), Rio de Janeiro 21941-904, Rio de Janeiro, Brazil
| | - Sonia Vivian de Jezus
- Sinop Campus, Federal University of Mato Grosso (UFMT), Sinop 78550-728, Mato Grosso, Brazil
| | - Vânia Maria Silva Araújo
- Brazilian Tuberculosis Research Network (REDE-TB), Rio de Janeiro 21941-904, Rio de Janeiro, Brazil
| | - Jair dos Santos Pinheiro
- State Tuberculosis Control Program of Amazonas, Manaus 69093-018, Amazonas, Brazil; (J.d.S.P.); (L.B.d.O.d.A.)
| | | | - Marvis Canelonez
- State Tuberculosis Control Program of Amazonas, Manaus 69093-018, Amazonas, Brazil; (J.d.S.P.); (L.B.d.O.d.A.)
| | | | - Freddy Perez
- Communicable Diseases Prevention, Control, and Elimination and Environmental Determinants of Health Department, Pan American Health Organization, Washington, DC 20037, USA;
- Department of Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre 90050-170, Rio Grande do Sul, Brazil
| | - Ethel Leonor Noia Maciel
- Ministry of Health, Secretariat for Health Surveillance and the Environment, Brasília 70058-900, Distrito Federal, Brazil
| | - Ricardo Alexandre Arcêncio
- Department of Maternal-Infant and Public Health Nursing, Ribeirão Preto College of Nursing, University of São Paulo, Ribeirão Preto 14040-902, Sao Paulo, Brazil; (Y.M.A.)
- Brazilian Tuberculosis Research Network (REDE-TB), Rio de Janeiro 21941-904, Rio de Janeiro, Brazil
| |
Collapse
|
2
|
Pramono JS, Ridwan A, Maria IL, Syam A, Russeng SS, Syamsuar, Mumang AA. Active Case Finding for Tuberculosis in Migrants: a Systematic Review. Med Arch 2024; 78:60-64. [PMID: 38481594 PMCID: PMC10928684 DOI: 10.5455/medarh.2024.78.60-64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Accepted: 01/31/2024] [Indexed: 07/23/2024] Open
Abstract
Background Active case finding (ACF) is an alternative strategy to accelerate the identification of TB cases among the migrant population. Objective This study aimed to synthesize the evidence for the effectiveness of ACF TB in migrants. Methods This study uses the PRISMA model as a method of searching for journal articles in the databases of Google Scholar, ProQuest, EBSCO, ScienceDirect, Elsevier, and PubMed, as well as other sources such as textbooks and reports from 2017 to 2021 with the keywords "tuberculosis" AND "active case finding" AND "migrant". The search revealed 371 articles, of which 26 met the criteria for further discussion. Results Most studies show that the TB incidence among migrants is higher than in the local population. Factors leading to increased cases include lack of knowledge about the symptoms, high mobilization, social isolation, economic problems, and medication adherence that impact an advanced stage. Furthermore, it is also influenced by the low quality of health services, including accessibility, health facilities, health workers, and information. Therefore, Active Case Finding (ACF) is more effective in identifying cases of TB in the risk groups. This was conducted on migrants with increased notifications followed up with treatment. Conclusion ACF is effective approach in screening and diagnosing TB in the migrant group.
Collapse
Affiliation(s)
- Joko Sapto Pramono
- Doctoral program of Public Health Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
| | - A Ridwan
- Department of Epidemiology, Public Health Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
| | - Ida Leida Maria
- Department of Epidemiology, Public Health Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
| | - Aminudin Syam
- Department of Nutrition, Public Health Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
| | - Syamsiar S. Russeng
- Department of Occupational Health and Safety, Public Health Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
| | - Syamsuar
- Department of Environmental Health, Public Health Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia
| | - Andi Agus Mumang
- Graduate School of Hasanuddin University, Makassar, South Sulawesi, Indonesia
| |
Collapse
|
3
|
Silva DR, Mello FCDQ, Johansen FDC, Centis R, D'Ambrosio L, Migliori GB. Migration and medical screening for tuberculosis. J Bras Pneumol 2023; 49:e20230051. [PMID: 37132706 PMCID: PMC10171264 DOI: 10.36416/1806-3756/e20230051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2023] [Accepted: 02/15/2023] [Indexed: 03/31/2023] Open
Abstract
Vulnerable populations, such as migrants and refugees, have an increased risk of tuberculosis disease, especially in the first years after arrival in the host country. The presence of migrants and refugees in Brazil exponentially grew over the period between 2011 and 2020, and approximately 1.3 million migrants from the Global South were estimated to be residing in Brazil, most of whom from Venezuela and Haiti. Tuberculosis control programs for migrants can be divided into pre- and post-migration screening strategies. Pre-migration screening aims to identify cases of tuberculosis infection (TBI) and can be carried out in the country of origin (pre-entry) or in the destination country (at entry). Pre-migration screening can also detect migrants at an increased risk of developing tuberculosis in the future. High-risk migrants are then followed up in post-migration screening. In Brazil, migrants are considered a priority group for the active search for tuberculosis cases. However, there is no recommendation or plan regarding screening for TBI in migrants and refugees. Ensuring prevention, diagnosis, and treatment for TBI and tuberculosis disease in migrant populations is an important aspect of tuberculosis control and elimination. In this review article, we address epidemiological aspects and access to health care for migrants in Brazil. In addition, the migration medical screening for tuberculosis was reviewed.
Collapse
Affiliation(s)
- Denise Rossato Silva
- . Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil
| | - Fernanda Carvalho de Queiroz Mello
- . Instituto de Doenças do Tórax - IDT - Faculdade de Medicina, Universidade Federal do Rio de Janeiro - UFRJ - Rio de Janeiro (RJ) Brasil
| | - Fernanda Dockhorn Costa Johansen
- . Brasil. Ministério da Saúde, Secretaria em Vigilância em Saúde e Ambiente, Coordenação-Geral de Vigilância da Tuberculose, Micoses Endêmicas e Micobactérias não Tuberculosas, Brasília (DF) Brasil
| | - Rosella Centis
- . Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri - IRCCS - Tradate, Italia
| | | | - Giovanni Battista Migliori
- . Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri - IRCCS - Tradate, Italia
| |
Collapse
|
4
|
Russo G, Marchese V, Formenti B, Cimaglia C, Di Rosario G, Cristini I, Magro P, El-Hamad I, Cirillo DM, Girardi E, Matteelli A. Screening for Tuberculosis Infection among Migrants: A Cost-Effectiveness Analysis in the Italian Context. Antibiotics (Basel) 2023; 12:antibiotics12040631. [PMID: 37106992 PMCID: PMC10135261 DOI: 10.3390/antibiotics12040631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 03/16/2023] [Accepted: 03/17/2023] [Indexed: 04/29/2023] Open
Abstract
BACKGROUND Screening of tuberculosis infection (TBI) among migrants from high-incidence countries is a cornerstone of tuberculosis control in low-incidence countries. However, the optimal screening strategy has not been defined yet. METHODS A quasi-experimental study involving migrants residing in the province of Brescia was carried out that aimed at assessing the completion rate, time to completion, preventive treatment initiation rate, and cost-effectiveness of two strategies for TBI screening. They underwent TBI screening with the IGRA-only strategy (arm 1) or with the sequential strategy (tuberculin skin test, TST, followed by IGRA in case of a positive result-arm 2). The two strategies were compared in terms of screening completion, time to complete the screening process, therapy initiation, and cost-effectiveness. RESULTS Between May 2019 and May 2022, 657 migrants were evaluated, and 599 subjects were included in the study, with 358 assigned to arm 1 and 237 to arm 2. Screening strategy was the only factor associated with screening completion in a multivariable analysis, with the subjects assigned to the IGRA-only strategy more likely to complete the screening cascade (n = 328, 91.6% vs. n = 202, 85.2%, IRR 1.08, 95% CI (1.01-1.14), p = 0.019). The time to complete the screening process was significantly longer for patients assigned to the sequential strategy arm (74 days vs. 46 days, p = 0.002). Therapy initiation did not significantly differ between the two arms, and cost-effectiveness was higher for the sequential strategy. CONCLUSION Sequential strategy implementation for TBI screening among migrants may be justified by its higher cost-effectiveness in spite of the lower completion of the screening cascade.
Collapse
Affiliation(s)
- Giulia Russo
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
- Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
| | - Valentina Marchese
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
- Department of Clinical and Experimental Sciences, WHO Collaborating Centre for Tuberculosis Prevention, University of Brescia, 25123 Brescia, Italy
- Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM), 20359 Hamburg, Germany
| | - Beatrice Formenti
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
- UNESCO Chair "Training and Empowering Human Resources for Health Development in Resource-Limited Countries", Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy
| | - Claudia Cimaglia
- Clinical Epidemiology Unit, Lazzaro Spallanzani National Institute for Infectious Diseases-IRCCS, 00149 Rome, Italy
| | - Gianluca Di Rosario
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
| | - Irene Cristini
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
| | - Paola Magro
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
| | - Issa El-Hamad
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
| | - Daniela Maria Cirillo
- Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
| | - Enrico Girardi
- Clinical Epidemiology Unit, Lazzaro Spallanzani National Institute for Infectious Diseases-IRCCS, 00149 Rome, Italy
| | - Alberto Matteelli
- Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili of Brescia, 25123 Brescia, Italy
- Department of Clinical and Experimental Sciences, WHO Collaborating Centre for Tuberculosis Prevention, University of Brescia, 25123 Brescia, Italy
| |
Collapse
|
5
|
Ramírez-Koctong O, Colorado A, Cruzado-Castro L, Marin-Samanez H, Lecca L. Observatorios sociales nacionales y regional de tuberculosis en ocho países de Latinoamérica y el Caribe. Rev Panam Salud Publica 2022; 46:e163. [DOI: 10.26633/rpsp.2022.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 07/11/2022] [Indexed: 11/24/2022] Open
Abstract
Poner fin a la tuberculosis (TB) requiere de un enfoque y participación multisectorial, incluyendo a la sociedad civil organizada. Entonces con el apoyo de un proyecto regional financiado por el Fondo Mundial (OBSERVA TB), desde el año 2019 se conformaron observatorios sociales de tuberculosis en 8 países de Latinoamérica y el Caribe (LAC) (Bolivia, Colombia, El Salvador, Guatemala, Haití, México, Perú y República Dominicana) y un Observatorio Social Regional de TB, como expresión de la implementación del enfoque ENGAGE-TB impulsado por la Organización Mundial de la Salud. Este artículo presenta el modelo de implementación, los avances y los desafíos de los observatorios sociales de tuberculosis. A diciembre de 2021, se incluyeron 135 organizaciones de la sociedad civil de LAC en los 8 observatorios implementados, espacios que sirven como plataformas para la vigilancia social, la incidencia política y el monitoreo social de las respuestas nacionales contra la TB, además de contribuir a los indicadores del ENGAGE-TB relacionados a la detección de casos TB y a los apoyos durante el tratamiento. Por ello, recomendamos la consolidación y expansión de los observatorios existentes, así como la participación de otros países de la región LAC.
Collapse
|
6
|
Di Gennaro F, Gualano G, Palmieri F. Antibiotics and Infectious Respiratory Diseases. Antibiotics (Basel) 2022; 11:antibiotics11070859. [PMID: 35884113 PMCID: PMC9312235 DOI: 10.3390/antibiotics11070859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Accepted: 06/22/2022] [Indexed: 11/16/2022] Open
Affiliation(s)
- Francesco Di Gennaro
- Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani” IRCCS, 00149 Rome, Italy; (G.G.); (F.P.)
- Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, 70123 Bari, Italy
- Correspondence:
| | - Gina Gualano
- Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani” IRCCS, 00149 Rome, Italy; (G.G.); (F.P.)
| | - Fabrizio Palmieri
- Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani” IRCCS, 00149 Rome, Italy; (G.G.); (F.P.)
| |
Collapse
|